trimethyloxamine has been researched along with cardiovascular agents in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dambrova, M; Grinberga, S; Kalvins, I; Konrade, I; Liepins, E; Petrovska, R; Pugovics, O; Skapare-Makarova, E; Tirzite, D | 1 |
| Fan, Y; Hazen, SL; Li, XS; Senthong, V; Tang, WH; Wang, Z; Wu, Y | 1 |
| Bondare, L; Cirule, H; Dambrova, M; Erglis, A; Grinberga, S; Hartmane, D; Latkovskis, G; Liepinsh, E; Makarova, E; Mazule, M | 1 |
1 trial(s) available for trimethyloxamine and cardiovascular agents
| Article | Year |
|---|---|
Meldonium decreases the diet-increased plasma levels of trimethylamine N-oxide, a metabolite associated with atherosclerosis.
Topics: Adult; Atherosclerosis; Cardiovascular Agents; Carnitine; Diet; Female; HEK293 Cells; Humans; Male; Methylamines; Methylhydrazines; Organic Cation Transport Proteins; Seafood; Solute Carrier Family 22 Member 5 | 2013 |
2 other study(ies) available for trimethyloxamine and cardiovascular agents
| Article | Year |
|---|---|
Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.
Topics: Aged; Cardiovascular Agents; Coronary Artery Disease; Coronary Stenosis; Epidemiologic Methods; Female; Gastrointestinal Microbiome; Humans; Male; Methylamines; Middle Aged; Myocardial Revascularization; Prognosis | 2016 |
Loop diuretics decrease the renal elimination rate and increase the plasma levels of trimethylamine-N-oxide.
Topics: Aged; Animals; Biomarkers; Cardiovascular Agents; Cardiovascular Diseases; Cross-Sectional Studies; Female; Heart; Humans; Kidney; Liver; Male; Methylamines; Mice; Middle Aged; Sodium Potassium Chloride Symporter Inhibitors | 2018 |